ASTH Astrana posts 11 percent Q4 2025 EPS beat shares rise modestly after earnings release IKT Inhibikase Therapeutics beats Q4 2025 loss estimates shares post modest gains following earnings release NWL Newell Brands narrowly misses Q4 2025 EPS estimates shares climb 355 percent on positive investor sentiment MDCXW Medicus management outlines latestage pipeline expansion as core strategic priority for future earnings growth